Naftifine
Back to searchMolecule Structure
Scientific Name
Naftifine
Brand Name(s)
Not Available
Company Owner(s)
Xiromed Pharma Espana Sl, Taro Pharmaceuticals Usa Inc, Tolmar Inc, Sebela Ireland Ltd, Taro Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Squalene monooxygenase | SINGLE PROTEIN | INHIBITOR | CHEMBL2364679 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL49141 | ||
| PharmGKB | PA164748617 | ||
| PubChem: Thomson Pharma | 14942609 | ||
| PubChem | 47641 | ||
| LINCS | LSM-43018 | ||
| Nikkaji | J19.990G | J3.124.773J | |
| BindingDB | 50170647 | ||
| EPA CompTox Dashboard | DTXSID6048545 | ||
| DrugCentral | 1872 | ||
| Brenda | 12270 | ||
| rxnorm | NAFTIN | NAFTIFINE HYDROCHLORIDE | NAFTIFINE |
| KEGG Ligand | C08071 | ||
| ChEBI | 7451 | ||
| ZINC | ZINC000001530977 |
